An excipient is an inactive substance formulated alongside an active ingredient to carry, stabilize, preserve, or enhance the dosage form of a medicine, vaccine, or biologic. In regulatory and manufacturing documentation, excipients are listed in formulation records, labels, summary-of-product-characteristics documents, patient information leaflets, and investigational brochures, where their names, grades, and functions must be translated with precision because they affect safety information.
Translators encounter excipients in patient-facing documents, such as package leaflets and summaries of product characteristics, where patients may have allergies, intolerances, or dietary restrictions that can affect safe use. They also appear in manufacturing records and labeling for global submissions, so consistency across documents and languages is essential to avoid safety-relevant omissions during translation and review.
A frequent mistake is treating excipients as optional background terms and paraphrasing them loosely in the target language, which can hide allergen warnings or change the intended formulation. Translators also confuse similar-sounding excipient names across pharmacopoeias or between brand and generic documents, leading to inconsistent labels that complicate regulatory review and can put patients at risk.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →